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Novel calcium-related targets of insulin in hippocampal neurons
Shaniya Maimaiti, Hilaree N. Frazier, Katie L. Anderson, Adam O. Ghoweri, Lawrence D. 
Brewer, Nada M. Porter, and Olivier Thibault
Department of Pharmacology and Nutritional Sciences, University of Kentucky Medical Center, 
UKMC, MS-310; 800 Rose Street, Lexington, KY 40536
Abstract
Both insulin signaling disruption and Ca2+ dysregulation are closely related to memory loss during 
aging and increase the vulnerability to Alzheimer's disease (AD). In hippocampal neurons, aging-
related changes in calcium regulatory pathways have been shown to lead to higher intracellular 
calcium levels and an increase in the Ca2+-dependent afterhyperpolarization (AHP), which is 
associated with cognitive decline. Recent studies suggest that insulin reduces the Ca2+-dependent 
AHP. Given the sensitivity of neurons to insulin and evidence that brain insulin signaling is 
reduced with age, insulin-mediated alterations in calcium homeostasis may underlie the beneficial 
actions of insulin in the brain. Indeed, increasing insulin signaling in the brain via intranasal 
delivery has yielded promising results such as improving memory in both clinical and animal 
studies. However, while several mechanisms have been proposed, few have focused on regulation 
on intracellular Ca2+. In the present study, we further examined the effects of acute insulin on 
calcium pathways in primary hippocampal neurons in culture. Using the whole-cell patch-clamp 
technique, we found that acute insulin delivery reduced voltage-gated calcium currents. Fura-2 
imaging was used to also address acute insulin effects on spontaneous and depolarization-
mediated Ca2+ transients. Results indicate that insulin reduced Ca2+ transients, which appears to 
have involved a reduction in ryanodine receptor function. Together, these results suggest insulin 
regulates pathways that control intracellular Ca2+ which may reduce the AHP and improve 
memory. This may be one mechanism contributing to improved memory recall in response to 
intranasal insulin therapy in the clinic.
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Introduction
Aging is a major risk factor for Alzheimer's disease (AD), and both brain aging and AD are 
characterized by a progressive decline in cognitive and memory function. A promising 
approach for the treatment of cognitive impairment in AD seeks to maintain or enhance 
insulin signaling in the brain. This approach is based on nearly two decades of research that 
provides support for strong associations between diabetes, cognitive decline, and AD (Ott et 
al., 1996; Leibson et al., 1997; Luchsinger, 2010; Bosco et al., 2011; De Felice, 2013). Other 
support comes from studies showing that insulin can act as a cognitive and neural modulator 
(Baura et al., 1993; Cholerton et al., 2011; Heni et al., 2014a; Sartorius et al., 2015). Insulin 
acting in the brain is synthesized by pancreatic β-cells and gains access to the brain via the 
blood brain barrier. In the periphery and in the brain, insulin has been shown to bind to 
insulin receptors and to regulate glucose uptake by inducing translocation of glucose 
transporters to the plasma membrane (McNay et al., 2013).
In aging or AD, declining insulin levels, insulin receptor numbers, and/or glucose 
transporters can lead to dysregulation in glucose uptake which may underlie cognitive 
decline (Schioth et al., 2012a). Indeed, there is evidence that insulin receptor numbers and 
their functions are decreased in aging and AD animal models (Zaia & Piantanelli, 1996; 
Frolich et al., 1998; Zhao et al., 2004; Zhao et al., 2008). At the cellular level, brain insulin 
deficiency and reduction in insulin signaling, perhaps mediated by insulin resistance, could 
represent one of the altered pathways linked to altered memory function or synaptic 
communication during aging and AD (Craft et al., 1996; Rasgon & Jarvik, 2004; de la 
Monte et al., 2006; Talbot et al., 2012; De Felice, 2013; Sasaoka et al., 2014; Maimaiti et al., 
2016). One approach to combat this reduction in insulin signaling that has received much 
interest clinically is the use of intranasal insulin delivery to selectively increase insulin 
concentration in the brain (Born et al., 2002).
The intranasal route of insulin administration raises insulin acutely in the central nervous 
system without much risk of peripheral hypoglycemia (Kern et al., 1999; Ott et al., 2014; 
Lochhead et al., 2015; Anderson et al., 2016; Maimaiti et al., 2016). Intranasal insulin 
therapy has been shown to improve memory function in AD patients and in healthy 
individuals (Benedict et al., 2004; Reger et al., 2006; Hanson & Frey, 2008; Reger et al., 
2008; Craft et al., 2012; Schioth et al., 2012b; Freiherr et al., 2013; Craft et al., 2017). 
Further, animal models of aging and AD also show the positive impact of intranasal insulin 
in combating cognitive decline (Francis et al., 2008; Marks et al., 2009; Apostolatos et al., 
2012; de la Monte, 2013; Adzovic et al., 2015; Salameh et al., 2015; Anderson et al., 2016; 
Maimaiti et al., 2016). Despite these promising outcomes, the mechanisms of action in the 
brain, and specifically on neurons of the hippocampus where insulin plays a recognizable 
role in learning and memory (Zhao et al., 1999; Zhao et al., 2004), remain largely unknown.
Because there is compelling evidence that aspects of cognitive aging may be due to calcium 
dysregulation that results in enhanced calcium levels (Porter et al., 1997; Thibault et al., 
2001; Clodfelter et al., 2002; Hemond & Jaffe, 2005; Gant et al., 2006; Oh et al., 2013) and 
voltage-gated calcium channels (VGCC) activity (Moyer et al., 1992; Thibault & Landfield, 
1996; Thibault et al., 2001; Nunez-Santana et al., 2014), we focused on studying two well-
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characterized calcium sources in hippocampal neurons. The rationale for this approach was 
based on recent evidence from our lab that insulin acutely reduces the calcium-dependent 
afterhyperpolarization (AHP) in neurons recorded from hippocampal slices (Pancani et al., 
2013; Maimaiti et al., 2016). The AHP is a hyperpolarization potential that is enhanced in 
aging, limits neuronal firing, and is associated with cognitive decline (Disterhoft et al., 1996; 
Tombaugh et al., 2005; Kadish et al., 2009; Pancani et al., 2013). The larger AHP seen in 
aging, is mediated in part, by an increase in the density of L-VGCCs (Thibault & Landfield, 
1996) and by calcium-induced calcium-release (CICR) through activation of ryanodine 
receptors (RyRs) (Kumar & Foster, 2005; Gant et al., 2006; Gant et al., 2013). Because we 
have also previously characterized these two calcium sources using neuronal depolarization 
protocols that evoke increases in intracellular calcium in hippocampal neurons (Attucci et 
al., 2002; Clodfelter et al., 2002; Gant et al., 2011), we sought to quantify their sensitivity to 
treatment with acute insulin. Here we used KCl-mediated long-lasting neuronal 
depolarization to activate large amplitude calcium transients under imaging conditions and 
also directly measure calcium influx in patch clamping experiments.
We tested the hypothesis that acute insulin (glulisine, zinc-free and fast acting) would reduce 
calcium levels, or promote calcium homeostasis by altering VGCC and/ or RyR function in 
cultured neurons. To address these questions, we used patch clamp recording of VGCCs 
with rapid drug delivery, as well as Fura-2 imaging during KCl-mediated depolarization in 
the presence or absence of a RyR blocker. Our results indicate that insulin is able to reduce 
intracellular calcium levels during periods of neuronal depolarization and that this is 
mediated, at least in part, by reductions in VGCC and RyR function. These two aging-
sensitive neuronal Ca2+ targets, therefore, are sensitive to the actions of insulin and could 
represent novel therapeutic targets for cognitive decline in aging and/ or AD. Re-establishing 
Ca2+ homeostasis represents a mechanism by which insulin and by extension, its targeted 
delivery to the brain (i.e., intranasal insulin), may offset learning and memory dysregulation 
in vivo.
Experimental Procedures
Cell culture
Hippocampal mixed (neuron/glia) cultures were prepared as described previously (Porter et 
al., 1997; Pancani et al., 2009; Pancani et al., 2011) and established from (E18) Sprague-
Dawley rats. E18 pups and hippocampi were dissected under a microscope in ice-cold 
Hank's balanced salt solution (Thermo Fisher Scientific Inc., MA, USA) supplemented with 
4.2 mM NaHCO3, 10 mg/L gentamicin and 12 mM HEPES (pH 7.3). Hippocampi were 
transferred to a 37°C 0.25 % Trypsin EDTA solution (Thermo Fisher) and left at room 
temperature for 11 minutes. Trypsin was removed and the hippocampi were washed three 
times with Minimum Essential Medium (MEM). Hippocampi were then titrated, and diluted 
with MEM to the desired final concentration (5-7 × 105 neurons/mL) before being plated 
onto 35 mm poly-L-lysine coated dishes. Cultured neurons were incubated (36°C, 5% CO2, 
95% O2) for 24 h before the first medium exchange. At this time, half of the medium was 
replaced with 90% SMEM supplemented with 10% Horse serum. After three days in vitro 
(DIV), half of the medium was replaced with SMEM, horse serum, 5-Fluoro-2-Dioxyuridine 
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and uridine to stop glial cell growth. At DIV 10, a sodium bicarbonate solution (200 μL) was 
added to help maintain pH and limit evaporation.
For whole-cell recording experiments, plastic culture dishes were used (Corning Inc., 
Corning, NY, USA) and for calcium imaging experiments, glass bottom culture dishes 
(Mattek Crop., Ashland MA, USA) were used. All data presented were collected between 
DIV 13 and 17, when neuronal connections, the density of VGCCs, and measures of cell 
survival are relatively stable (Porter et al., 1997; Blalock et al., 1999). All experiments were 
conducted following 24 h exposure to a lower glucose-containing MEM (5.5 mM; MEM 
with no added glucose). This was done to maintain relatively normal glucose oxidation rates 
and insulin sensitivity (Pancani et al., 2011). All data presented were obtained at room 
temperature.
VGCC recording solution
External recording solution of VGCC currents was as follows (in mM): 111 NaCl, 5 
BaCl.H2O, 5 CsCl, 2 MgCl2, 10 glucose, 10 HEPES, 20 TEA.Cl.H2O, pH 7.35 with NaOH, 
and 500 nM tetrodotoxin (TTX) was added before recording to inhibit Na+ channels. The 
internal pipette solution (in mM): 145 CH4O3S-methanesulfonic acid, 10 HEPES, 3 MgCl2, 
11 EGTA, 1 CaCl2, 13 TEA.Cl.H2O, 14 phosphocreatine Tris-salt, 4 Tris-ATP, 0.3 Tris-GTP, 
pH 7.3 with CsOH. All solutions were sterile filtered.
Drugs and solution application
External solutions were delivered using a rapid solution exchange system (SF77A - Warner 
Instruments Corp. Hamden, CT, USA) positioned approximately 400 μm above the cell 
being recorded. Flow rate was set to 0.3 mL/min and a control solution supplemented with 
TTX was used to establish baseline recording (∼10 min) during which passive cell 
membrane properties were obtained (e.g., membrane resistance, capacitance, access 
resistance), and currents were allowed to run up. Rapidly switching the position of the 
tubing delivering the external solutions above the recorded or imaged cell allowed us to 
control the environment and deliver either insulin, KCl (50 mM), ryanodine (20 μM), a high-
affinity small peptide interacting with insulin (affibody, ab31906, Abcam, Cambridge, MA, 
USA; 100 g/mL, 500 ng/mL, or 1 μg/mL), or an insulin receptor antibody (S961, Phoenix 
Pharmaceuticals Inc., Burlingame, CA., USA; 500 ng/mL). Insulin glulisine (10 nM, a fast 
acting, zinc-free insulin) was prepared weekly in external recording solution from a 6 μM 
stock (Apidra®, Sanofi-Avantis US. LLC, diluted in sterile saline). This concentration was 
chosen based on previous results from our lab (Pancani et al., 2013; Maimaiti et al., 2016).
Whole-cell recording and analysis
To minimize capacitance artifacts, whole-cell patch-clamp electrodes were coated with 
polystyrene Q-dope before recording (see Table 1 for membrane and electrode properties). 
The culture dish was rinsed with external solution twice and then supplemented with TTX. 
Current/voltage (I-V) relationships (−60 to + 30 mV) were used to identify the voltage step 
eliciting the maximal current amplitude. This voltage was used for each cell in the study in 
order to compare data at the peak of the I-V relationship (150 ms depolarization). Cells were 
either held at −70 mV or −40 mV and currents were elicited (every 30 s) at the maximal 
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peak response. All currents were leak subtracted using 5-8 scaled hyperpolarizing sub-
pulses. Currents were recorded once stable and for 10 min of either control or insulin 
solution (last 2 min of each condition was averaged). Because insulin may alter cell size, we 
report on measures of current densities (pA/pF), derived from dividing peak current 
amplitude by membrane capacitance (measured in pClamp) for each cell. All recordings 
were conducted on the stage of an epifluorescence microscope (E600FN - Nikon Inc., 
Melville, NY, USA) placed on an anti-vibration table. An amplifier (Axopatch 1D - 
Molecular Devices, Sunnyvale, CA, USA) in combination with an A/D board (Digidata 
1200 - Molecular Devices) and acquisition software (pClamp 7 - Molecular Devices) were 
used for electrophysiology acquisition. Data were digitized at 5-10 KHz, low-pass filtered at 
2-5 KHz, and were quantified in Clampfit 7 (Molecular Devices).
Ca2+ imaging and analysis
Cultures were incubated in Ca2+ imaging solution (in mM): 145 NaCl, 2.5 KCl, 10 HEPES, 
10 D-glucose, 2 CaCl2, 1MgCl2, 0.01 glycine, pH 7.3 with NaOH for 30 min in the dark. 
This solution contained 2 μM Fura-2 AM (F1221 – Invitrogen) that was made monthly with 
fresh DMSO (0.085%) and Pluronic® F-127 (0.015%, weight/ volume). Each culture dish 
was then rinsed three times with Ca2+ imaging solution containing no indicator and placed 
in the dark for 20 min (de-esterification period). The dish was then placed on the stage of the 
microscope. Intracellular Ca2+ transients were visualized by exciting Fura-2 at 340 +/−20 
nm and 380 +/− 20 nm using a high-speed filter changer (Lambda DG4, Sutter instruments, 
Novato, CA, USA) to obtain a ratiometric value independent of indicator concentration. 
Emitted light was passed through a dichroic filter (400 nm high pass) and an emitter filter 
(520 +/− 30 nm; Chroma Technology) and was digitized onto the sensor of an EMCCD 
camera (iXon-Andor Technology, Belfast, Ireland). Acquisition speed for spontaneous Ca2+ 
transients (Figure 2) and resting Ca2+ measures (Figure 3) was set to one ratio every 30 s. In 
order to better define the peak of the Ca2+ transient during KCl-mediated depolarization, 
acquisition speed was increased to one ratio every 5 s. For measures on spontaneous calcium 
transients (AUC, delta peak ratio, and number of events) all data were normalized to 
baseline (periods of non-activity). We integrated the AUC during 10 minutes of control 
solution perfusion, and insulin perfusion, and also quantified the amplitude of the largest 
calcium transient (delta peak) and the number of events in those time periods. Events were 
counted if their amplitude was greater than 25% of the peak calcium transient during a 10 
min period. All calcium measures were analyzed using Imaging Workbench 5.0 (INDEC 
BioSystems, Santa Clara, CA) as previously published (Pancani et al., 2009; Pancani et al., 
2011). Measures were taken during two 10 min periods of imaging solution perfusion (Time 
Control) or during a 10 min period of control solution, followed by 10 min of insulin 
perfusion (Insulin). The greater ratio (340/380 nm) values reported reflect higher Ca2+ 
levels. The gray value for both excitation wavelengths of each cell measured (region-of-
interest - ROI drawn around soma) was background subtracted from an area devoid of 
cellular components. When imaging calcium during periods of depolarization (50 mM KCl), 
the Ca2+ imaging solution was modified with a reduction in NaCl to 97 mM in order to 
control for osmolarity changes.
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Statistics—Data were analyzed using Prism 5.0 (GraphPad Software, La Jolla, CA, USA). 
Because all variables analyzed were obtained before and after control or insulin solutions, 
either paired t-tests or ANOVAs (1-way or repeated) were used to test for group differences. 
When using ANOVAs to test for significance, Bonferroni's multiple comparison test were 
used as post-hoc tests. We tested for normal distributions and equal variances of all data 
presented, and equal variance was found in all groups. In cases where the normal 
distribution criterion was not met (Figures 1C left, 1F right; 2D, and 3C right), a Wilcoxon 
signed rank test was used and the median with interquartile range are presented. Significance 
was set at p< 0.05. For electrophysiology experiments, data from each recorded cell 
(solution perfusion precluded recording more than one cell per dish) was considered a single 
data point (i.e., n=1). For calcium imaging data, 5-10 cells in the field of view were averaged 
and considered a single data point (i.e., n=1). The data presented here are derived from 32 
dams and over 550 imaged or recorded neurons in culture.
Results
Effect of insulin on whole-cell Ca2+currents
Ca2+ currents were recorded before and after a 10 min perfusion of either external solution 
(time control; n=19), or external solution supplemented with 10 nM insulin (n=17) using the 
SF77A fast perfusion system. Cells were held at −70 mV and were stepped to the peak 
voltage determined from the I-V relationship. Peak and late currents (obtained immediately 
prior to termination of the voltage step) were quantified and are presented normalized to cell 
size (pA/pF). A significant decrease in peak (−20%; p<0.0001; paired t-test) and late (−31%, 
p<0.002; paired t-test) Ca2+ currents in response to acute insulin application was seen 
(Figure 1A-C). Based on a subset of the cells recorded (n=7 per group), there was no change 
in the I-V relationship (Figure 1D). Recovery experiments (10-15 min washout following 
interruption of insulin) did not succeed, likely due to current rundown during this extended 
recording period.
To determine if the actions of insulin were selective for different Ca2+ channels, cells were 
held at −40 mV and stepped (350 ms) to peak voltage. Analysis indicated that similarly to 
reductions seen from a holding potential of −70 mV, L-type-enriched Ca2+ currents were 
significantly reduced (Figure 1E and F) both at the peak (−22%; p<0.0004; Wilcoxon rank 
test) and during the late current phase (−33%; p<0.005; paired t-test). The data also suggest 
that irrespective of holding potential, insulin did not alter the inactivation rate of currents 
(Figures 1A and 1E), and did not show a greater inhibitory effect on currents elicited from 
−40 mV. Together, these results indicate insulin does not selectively reduce L-VGCCs but 
instead, may reduce all VGCCs.
Effect of insulin on spontaneous Ca2+ transients
We then used ratiometric calcium imaging to test whether insulin could alter spontaneous 
activity in cultured neurons. We used a similar experimental time frame as presented in 
Figure 1 and quantified calcium oscillations during 10 min of Ca2+ imaging solution 
perfusion (time control; n=11) and during 10 minutes when the solution was supplemented 
with 10 nM insulin (n=14). Insulin did not change spontaneous network activity (no TTX) 
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derived from measures of spontaneous Ca2+ events (Figure 2A – right). Those include 
measures of cumulative area-under-the curve measures during 10 minute periods either 
under control or insulin presentation (AUC; Figure 2B; p>0.05; paired t-test), peak transient 
amplitude (Figure 2C; p>0.05; paired t-test), and the number of spontaneous events detected 
(Figure 2D; p>0.05; Wilcoxon rank test). These spontaneous Ca2+ transients were 
completeley blocked by TTX (data not shown).
Effect of insulin on KCl-mediated Ca2+ transients
To induce larger and more predictable calcium transients, we used a potassium-mediated 
depolarization (30 s) in Ca2+ imaging experimental conditions and investigated the impact of 
insulin. This approach causes membrane depolarization with subsequent activation of 
VGCCs and calcium influx through the plasma membrane, which in turn, activates calcium-
induced calcium-release (CICR) from the endoplasmic reticulum through activation of RyRs 
(Sukhareva et al., 2002; Berrout & Isokawa, 2009; Pancani et al., 2011). Potassium-induced 
Ca2+ transients were reduced by 10 min of insulin perfusion (n=23) compared to 10 min of 
Ca2+ imaging perfusion (time control; n=14; Figure 3A and B). Consistent with the results 
on spontaneous calcium fluctuations, insulin did not reduce resting Ca2+ levels measured 
immediately prior to the depolarization (Figure 3D), or the peak of the calcium responses 
(Figure 3C). However, measures of the AUC of the calcium transient unmasked a significant 
insulin-mediate reduction (Figure 3B; p<0.0001; paired t-test). Attempts to reverse this 
effect by washing out insulin for 10-20 minutes did not succeed, indicating the impact of 
insulin may be long-lasting under these conditions. Of interest, the reduction in the 
potassium-mediated Ca2+ response seemed to selectively reduce the delayed calcium 
component or “hump”, present after the peak response (Figure 3A, bottom right). Because in 
a subset of cells, shorter potassium depolarizations (5 s) also induced a hump (see examples 
in Figure 3E), and small humps are also occasionally seen under spontaneous oscillations 
conditions (i.e., Figure 2), we believe this delayed response is not an artifact of long duration 
depolarizations. Instead, we believe this highlights a potential link to the activation of CICR 
mechanisms, given that this response by nature is often delayed compared to an initiating 
and rapid calcium spike most likely triggered by VGCCs.
Insulin appears to reduce CICR function
To test whether the reduction in the “hump” during potassium-induced depolarization 
reflected inhibition of the CICR component, we used high concentrations of ryanodine (20 
uM) which significantly reduce CICR (Clodfelter et al., 2002; Gant et al., 2006). These 
experiments required three repeated potassium depolarizations each separated by 10 min 
(time control; Figure 4). To test for the impact of ryanodine and/ or insulin, the first 
depolarization was triggered after 2 min of imaging solution perfusion, the second 
depolarization occurred after 10 min of ryanodine perfusion, and the third depolarization 
was after an additional 10 min of insulin perfusion (Figure 4A). As shown in Figure 4A and 
C, blocking CICR with ryanodine during potassium mediated depolarization (n=10) 
significantly reduced the “hump” after the initial high amplitude transient (Figure 4C, F(2,29) 
= 53.8; p <0.0001; RM ANOVA). As consistently shown throughout, time control 
experiments show no significant difference in the variables measured (n=11).
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No further reduction in the hump was seen when insulin was added to ryanodine treated 
cells, indicating that high ryanodine concentration may have occluded the impact of insulin. 
The lack of an additive effect between insulin and ryanodine actions suggests insulin may 
reduce CICR by inhibiting ryanodine receptors. Analysis of the peak calcium transient 
heights (delta peak Figure 4B) shows no significant differences across conditions. While this 
is surprising due to the results of Figure 1 showing insulin reduces VGCC, it is important to 
note that VGCC and RyR are in series and signals tend to merge in calcium imaging 
experiments. Further, the relatively rapid inactivating nature of VGCCs (calcium and/ or 
voltage) combined with a relatively slow calcium acquisition speed in these conditions (one 
ratio/ 5 s) preclude us from reliably identify the VGCC component during imaging 
experiments.
Insulin actions occur via occupation of the insulin receptor
To investigate whether 1) components other than insulin in the glulisine formulation, or 
whether 2) the actions of insulin were mediated via occupation of the insulin receptor, we 
used an insulin binding peptide (i.e., affibody) and an anti-insulin receptor antibody, 
respectively. For these experiments, we used the same experimental protocol as presented in 
Figure 3 with two potassium-mediated depolarization 10 min apart. Either the affibody 
peptide (n=6-16 per condition) or the antibody (n=9) was used. The results are again 
compared to time controls with perfusion of imaging solution (n=16). While lower doses of 
the affibody (100 ng and 500 ng/mL) did not prevent the insulin-mediated reductions in the 
calcium AUC (Figure 5A, p<0.01 and p<0.05, respectively, ANOVA), a higher dose (1 
μg/ml) was able to completely inhibit this effect such that the reduction in AUC was no 
longer present (p>0.05; ANOVA). Doses used are modelled after in vivo studies (Paranjape 
et al., 2010; Luckett et al., 2013). Given that we did not perform similar blocking 
experiments on recorded cells (e.g., Figure 1), we cannot address whether the impact of 
insulin on calcium currents requires insulin binding to its own receptor. Nevertheless, the 
results presented here using imaging conditions suggest that the effects of insulin on 
hippocampal Ca2+ levels were mediated through activation of insulin receptors (Figure 5B - 
right).
Discussion
The experiments described here characterized the impact of acute insulin exposure on 
neuronal calcium currents and calcium levels. The techniques used provide the most direct 
approach for analyses on the impact of insulin on hippocampal neurons without the 
confounding interactions of blood vessels and other cell types. Cultured neurons provide a 
simplified environment where acute drug exposure is rapid and direct, free from the 
diffusion hindrance of the brain parenchyma or vascular interactions. Similar approaches in 
our lab and others have revealed significant connections between the actions of hormones 
and neuronal function (Clodfelter et al., 2002; Pancani et al., 2011). Our results provide 
evidence that Apidra, a zinc-free insulin formulation, is able to reduce VGCC currents and 
calcium levels attained during neuronal depolarization. The mechanism is dependent on 
insulin receptor activation, and also appears to engage ryanodine receptors as CICR 
contributions were reduced in response to acute insulin treatment.
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Calcium currents are a target of acute insulin in neurons
The insulin-mediated reduction in whole-cell calcium currents does not appear to be specific 
to one subtype of VGCC. This is supported by evidence of currents recorded from −70 mV 
and −40 mV before and approximately 10 minutes after the addition of 10 nM insulin, 
showing the same degree of inhibition for the peak and late currents (i.e., similar inactivation 
rates before and after insulin in Figures 1A and 1E). This similar current decay argues for 
the reduction of a noninactivating current. Furthermore, the insulin-induced reduction in 
currents elicited from a holding potential of −40 mV, a potential favoring recording of L-
type calcium currents, was not significantly greater in amplitude compared to the inhibition 
seen from −70 mV, arguing against a selective effect of insulin on L-type calcium channels. 
If N-type currents were selectively reduced by insulin, one would expect reductions from 
−70 mV but not from a holding potential of −40 mV. Conversely, if L-VGCC were 
selectively reduced by insulin, one would expect a great reduction in current from −40 mV 
(enriched in L-type since N-type are voltage inactivated), compared to holding at −70 mV. 
Previous work on regulation of VGCC in different cell types also notes that the effect of 
insulin may not be selective for a particular type of VGCC (e.g., N- or L-type VGCCs; 
(Strauss et al., 1997; Wijetunge et al., 2002).
This insulin mediated reduction in VGCC was not accompanied by a shift in the I-V 
relationship (Figure 1D), indicating the mechanism likely impacts flux of the charge carrier 
through the channels rather than alterations in the voltage sensitivity or inactivation 
properties of the channels. Insulin may mediate VGCC reduction through a mechanism 
involving tyrosine phosphorylation. Indeed, prior work in pinealocytes and photoreceptors, 
showing that tyrosine phosphorylation can reduce L-VGCC function (Chik et al., 1997; 
Stella et al., 2001). Evidence also suggests that the pore-forming alpha subunit of some 
VGCCs can be regulated directly by tyrosine residue phosphorylation (Strauss et al., 1997; 
Potier & Rovira, 1999; Wijetunge et al., 2002). Prior work has shown that acute insulin can 
alter other ion channels including large conductance Ca2+-activated potassium channels 
(BK-type). Under these conditions, insulin reduced somatic calcium levels during 
spontaneous oscillations in cultured hippocampal neurons (O'Malley & Harvey, 2007). 
Further, given the evidence that reductions in Src binding to the alpha 1 subunit of the L-
VGCC significantly reduces channel current amplitude in cardiac myocytes (Dubuis et al., 
2006) and that insulin can reduce Src activity (Arbet-Engels et al., 1999), this signaling 
pathway likely highlights another potential mechanism by which insulin reduces VGCC 
current flux.
Still, it should be noted that some cells respond to tyrosine kinase phosphorylation with 
enhanced VGCC function and potentiated calcium levels (Bence-Hanulec et al., 2000; Paez 
et al., 2010), and that given the complexity of second messenger systems working through 
many kinases and phosphatases (Dolphin, 2016), the exact impact of insulin on VGCC likely 
depends on the presence and state of activation of other interacting pathways (i.e., PKA, 
PKC, AKAP, phosphatases, etc.). Irrespective of the mechanism of inhibition of VGCC by 
insulin, it is clear that VGCC are a target of insulin in neurons. The effect described here, 
therefore, is likely to mediate the beneficial impact of the hormone on cognitive function 
following intranasal delivery in animal models (Apostolatos et al., 2012; Adzovic et al., 
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2015; Anderson et al., 2016; Maimaiti et al., 2016) and in early AD subjects (Reger et al., 
2006; Reger et al., 2008; Craft et al., 2012; Freiherr et al., 2013; Rosenbloom et al., 2014; 
Claxton et al., 2015). Indeed, according to the calcium hypothesis of aging and dementia 
(Landfield, 1987; Khachaturian, 1989; Alzheimer's Association Calcium Hypothesis, 2017), 
reducing calcium levels in postsynaptic neurons is a favorable approach to offset cognitive 
decline in aging and AD (see below).
Other potential targets of insulin actions
Previous work shows insulin can increase cell surface expression of NMDA receptors 
(Skeberdis et al., 2001) and can reduce surface expression of AMPA receptors (Lin et al., 
2000; Man et al., 2000). These studies employed similar insulin exposure time as used in the 
current study, but concentrations were 50-1000 fold higher. Thus, it is not clear whether 
transient changes in NMDA and AMPA surface expression would manifest using 10 nM 
insulin. As reported in Figure 2, the nearly physiological insulin concentration used here 
does not necessarily alter network excitability.
This is evidenced by a lack of insulin action on peak transient amplitude of the spontaneous 
calcium responses, the AUC of the spontaneous events, as well as the number of 
spontaneous events. Our work, therefore, may suggest that higher concentrations of insulin 
are needed to alter network oscillations, overall excitability and spontaneous activity. 
Alternatively, the ability to detect calcium changes using ratiometric Fura-2 imaging is 
somewhat restricted when compared to the speed of electrophysiological acquisition 
systems, and this may limit the ability to detect the more subtle and transient impact of 
insulin on network spontaneous activity. Although not tested directly here, our results also 
do not provide evidence that insulin can increase surface expression of GABAA receptors 
(Wan et al., 1997; Vetiska et al., 2007) which should have reduced excitability. Within the 
period tested (∼10 minutes) and at the low concentration used, we did not see evidence of 
depression in spontaneous calcium events (Figure 2). Thus, further studies focusing on 
insulin concentration-responses and time of exposure are needed to clarify these 
discrepancies. Of course, it will also be important to address the different types of available 
insulin formulations and to include the adequate zinc controls, given that almost all insulin 
formulations are zinc-based.
While insulin did not alter spontaneous calcium activity and calcium events amplitudes 
within the network of cells in culture (Figure 2), we did notice a significant alteration in the 
shape of the potassium-mediated calcium responses following insulin treatment (Figure 3). 
The disappearance of the “hump” following the peak calcium rise revealed the possibility 
that RyRs might be sensitive to insulin. We tested this hypothesis by pretreating the cultures 
with high concentrations of ryanodine to inhibit calcium-induced calcium release (CICR). 
As shown here, ryanodine pretreatment precluded further insulin-mediated inhibition of the 
calcium response to depolarization (Figure 4). This suggests insulin is capable of reducing 
CICR. This result is in line with prior evidence that neuronal store-operated Ca2+ channels 
(SOCCs) responsible for a small but significant secondary calcium entry pathway for 
replenishing the endoplasmic reticulum, are also a target of protein tyrosine phosphorylation 
(Koss et al., 2009), although it appears tyrosine phosphorylation may enhance this function. 
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Of interest, RyR are rapidly tyrosine phosphorylated upon activation in activated T-
lymphocytes (Guse et al., 2001) and growth hormone can tyrosine phosphorylate RyR in a 
β-cell-derived cell line (Zhang et al., 2004). Prior work has also shown that insulin can elicit 
an increase in calcium release through activation of RyR in muscle cells (Contreras-Ferrat et 
al., 2014). Future studies are necessary to identify if RyR subtypes can respond differently to 
insulin, whether these effects are tissue specific, dependent on particular signaling pathways, 
or whether sarcoplasmic-endoplasmic Ca2+-ATPases (SERCAs) function also is sensitive to 
insulin.
We suggest that the novel finding of insulin actions on CICR could be highly beneficial to 
neurons and to calcium dysregulation seen in aging and/ or AD, and that this new target 
potentially offers a secondary level of protection from sustained calcium-related actions in 
neurons. While it is not clear that the reduction in the “hump” (Figure 4) may provide a 
neuroprotective effect to neurons, the insulin-mediated reduction in depolarization observed 
during this calcium response could well keep neurons engaged during periods of activation.
Learning and memory selective actions of insulin in the brain
Past work studying insulin function in the brain identified critical links to learning and 
memory. Whether exogenous insulin on hippocampal neurons worked through changes in 
GABA, NMDA, AMPA, or even glucose transporters, it was understood that insulin could 
have a specific and selective impact on learning and memory and conversely, that learning 
also could have an impact on insulin receptors (Zhao et al., 1999; Dou et al., 2005). More 
recent analyses of insulin actions provide evidence that large and diverse areas of the CNS 
are indeed sensitive to insulin. Previous work shows insulin is a dynamic hormone with a 
rich influence on brain function.
Insulin stimulates the translocation of glucose transporter-4 to plasma membranes of 
hippocampal neurons within 15-30 min (Grillo et al., 2009). This rapid process is likely to 
regulate neuronal metabolic demands and the energy needed for learning and memory 
processing. In addition, insulin enhances synaptic plasticity by increasing the expression of 
dendritic postsynaptic density scaffolding protein (PSD-95), a key element of postsynaptic 
junctions in hippocampal neurons (Lee et al., 2005). Together these functions and their 
sensitivity to insulin undoubtedly contribute to improved encoding of synaptic information 
for the storage, and perhaps, the retrieval of memories.
Equally significant examples of the links between insulin and memory come from evidence 
that insulin can acutely reduce the hippocampal AHP, a calcium-dependent hyperpolarizing 
potential, which maintains hyperpolarization and precludes action potential threshold from 
being reached (Pancani et al., 2013; Maimaiti et al., 2016). The AHP is larger in aged 
compared to young animals (Landfield & Pitler, 1984; Potier et al., 1992; Disterhoft et al., 
1996; Hemond & Jaffe, 2005; Tombaugh et al., 2005; Kumar & Foster, 2007; Gant et al., 
2011), thus reducing the amplitude or duration of this hyperpolarizing potential may help 
combat age-related memory dysregulation by allowing cells to participate within a 
functional network (Gant & Thibault, 2009). Indeed, it has been shown that elevating 
potassium channel activity impairs learning (McKay et al., 2012), while lowering L-VGCC 
contribution to the AHP reduces the AHP (Moyer et al., 1992; Gamelli et al., 2011) and 
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enhances learning (Deyo et al., 1989; Moyer et al., 1992). Moreover, increasing cholinergic 
neurotransmission which enhances cellular excitability also can enhance learning (Saar et 
al., 1998; Oh et al., 1999; Saar et al., 2001; Disterhoft & Oh, 2006).
The evidence of robust insulin actions linked to memory processes or processes capable of 
facilitating memory encoding (e.g., metabolism, blood flow), does not detract from the 
traditional role of insulin in glucose homeostasis (Vianna & Coppari, 2011; Heni et al., 
2014b). Indeed, it is becoming very clear that once in the brain, the hormone is not limited 
in function to a single or even a few target areas (Kullmann et al., 2013; Kullmann et al., 
2015), strengthening its position as a potential therapeutic target which requires further 
research emphasis.
Conclusions
We used imaging and electrophysiology techniques to show that zinc-free insulin has rapid 
and selective effects on calcium sensitive functions in neurons, and that the effects are 
dependent on insulin activating the insulin receptor (Figure 5). This clearly engages a series 
of intracellular signals that through uncharacterized pathways or mechanisms, lead to rapid 
calcium reductions during neuronal depolarization. More research will need to be conducted 
to fully characterize the underlying mechanism and to address the selectivity of the effect 
using different insulin formulations. Importantly, our research and those of others show that 
reducing calcium dysregulation in brain aging, AD and in neuronal cultures has generally 
been associated with positive and neuroprotective outcomes, from improving cognitive 
functions to reducing cellular toxicity. We present evidence here that insulin could well be 
an endogenous modulator of these functions.
Reductions in insulin levels or in insulin signaling in the brain during aging and in AD may 
highlight one of the mechanisms that could reduce metabolism, thereby reducing cognitive 
function. However, our results also suggest that replacing insulin or enhancing insulin 
signaling in the brain of aging, or early AD subjects may be a valuable approach. We 
emphasize that the novel impact of insulin on neurons presented here could well underlie the 
beneficial impact of intranasal insulin on cognitive enhancement in the clinic and in animal 
studies. An important caveat is that it is not clear from our data whether insulin is able to 
alter calcium homeostasis in vivo, nor is it clear that KCl depolarizations used here reflect 
activation of processes that are also initiated in the hippocampus during synaptic activation, 
albeit in more restricted time periods (i.e., single action potentials or bursts of activity). If 
insulin is able to reduce calcium levels in vivo, the noted reductions in insulin-sensitive 
calcium responses may offset brain aging processes and ultimately, offset the impact of 
dementia on brain function.
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Abbreviations
AHP afterhyperpolarization
VGCC voltage-gated Ca2+ channel
AD Alzheimer's disease
KCl potassium chloride
RyR ryanodine receptor
Rya ryanodine
SEM standard error of the mean
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TTX tetrodotoxin, CICR, calcium-induced calcium-release
AUC area-under-the-curve
ROI region-of-interest
SERCA sarcoplasmic-endoplasmic Ca2+-ATPase
L-VGCC L-type voltage-gated Ca2+ current
SOCCs store-operated calcium channels
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Highlights
• Acute insulin reduces VGCC currents and calcium levels in hippocampal 
neurons
• Ryanodine receptors appear to be sensitive to insulin
• Insulin-mediated interactions with calcium signaling pathways may underlie 
its cognitive enhancement effects
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Figure 1. 
Calcium channel currents are reduced in response to acute insulin application in mixed 
hippocampal cultured neurons. A. Example of VGCC currents recorded during recording 
solution perfusion (black) and after 10 min insulin (grey) during maximal step 
depolarization from −70 mV. B.-C. Quantification across groups of cells following 10 min 
of insulin perfusion (Insulin) versus recording solution perfusion (Time Control) shows peak 
and late Ca2+ currents were significantly reduced (p<0.05). D. In a subgroup of cells, 
current-voltage relationships were not significantly altered. E. Example of the effects of 
insulin on L-VGCCs recorded from a holding potential of −40 mV during recording solution 
perfusion (black) and after 10 min insulin perfusion (gray). F.-G. Compared to time control, 
recordings from −40 mV, max peak (F) and late Ca2+ current (G) were significantly reduced 
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by insulin (p<0.05). The effect of insulin on VGCC does not appear to be L-VGCC 
selective. Data are presented as mean +/− SEM except for data in F, right, which represent 
median with interquartile ranges. Data are normalized to cell size (density, pA/pF) and 
asterisks indicate significance at the p<0.05 level.
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Figure 2. 
Spontaneous Ca2+ transients are not altered in response to acute insulin exposure. A. 
Example of neurons and ROI selection (green circles and numbered arrows- left). 
Calibration bar = 10 μm. Right shows spontaneous activity in the three ROIs (used to 
quantify insulin-mediated changes). Measures were taken during two 10 min periods of 
imaging solution perfusion (Time Control) or during a 10 min period of control solution 
followed by 10 min of insulin perfusion (Insulin). B.-D. Insulin perfusion did not change 
spontaneous calcium activity based on measures of AUC, peak transient amplitude, or the 
number of events detected. Data are presented as mean +/− SEM except for data in D, which 
represent median with interquartile ranges.
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Figure 3. 
Effects of insulin on KCl-induced depolarization. A. Pseudocolored images of cells in 
culture during Fura-2 imaged at rest (left) and during peak depolarization (right). Calibration 
bar = 10 μm. Red colors indicate greater levels of calcium (higher ratios). Two sequential 
KCl depolarizations were separated by 10 minutes of either control solution or insulin. 
Representative calcium transients are shown and highlight measures of resting calcium, peak 
calcium and AUC. Note the selective effect of insulin on reducing the late phase of the 
calcium transient, essentially eliminating the “hump”. B. Ratiometric quantification during 
time control experiments or after insulin shows the AUC resulting from KCl-induced 
depolarization was significantly decreased by insulin. C.-D. Peak ratio or resting ratio 
measures were not altered by insulin. Data are presented as mean +/− SEM except for data 
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in C, right, which represent median with interquartile ranges. Asterisks indicate significance 
at the p<0.05 level.
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Fig 4. 
Ryanodine receptors are likely targets of insulin actions. A. Three sequential KCl-mediated 
depolarizations were used in these experiments and were triggered under imaging solution 
perfusion (left) and during perfusion with ryanodine, or insulin (right). Representative 
ratiometric calcium transients highlight the impact of inhibiting CICR with ryanodine on the 
“hump”. Addition of insulin did not further reduce the “hump”. B. Peak ratios were not 
different across groups. C. Quantification across the groups of cells imaged shows ryanodine 
(Rya) significantly reduced the “hump”, indicating ryanodine and insulin may both be 
working on inhibition of RyRs. All data represent mean +/− SEM. Asterisks indicate 
significance at the p<0.05 level.
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Fig 5. 
Anti-insulin affibody peptide and anti-insulin receptor antibody inhibited insulin actions on 
KCl-mediated Ca2+ transients. Experiments were conducted as in Figure 3, with 2 sequential 
KCl depolarizations. A. High-dose (1 μg/mL) anti-insulin affibody neutralized the effect of 
insulin on KCl-induced Ca2+ transients while lower concentrations (100 ng/mL and 500 
ng/mL) did not. B. 500 ng/mL insulin receptor antibody also was able to inhibit insulin 
actions on the KCl-mediated Ca2+ transients. These results indicate the actions reported here 
on calcium homeostasis are mediated by insulin working on insulin receptors. All data 
represent mean +/− SEM. Asterisks indicate significance at the p<0.05 level.
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Table 1
Passive membrane properties and patch clamping parameters
All data presented are means ± SEM on measurements from patched neurons in Figure 1. Capacitance, 
membrane resistance, access resistance, and holding current measures were not significantly different across 
the groups.
Group Capacitance (pF) Membrane resistance (MΩ) Access resistance (MΩ) Holding current (pA)
Time Control (n=17) 50.8 ± 3.9 432.9 ± 32.0 10.6 ± 0.9 −102 ± 8.6
Insulin (n=19) 56.2 ± 3.5 415 ± 34.8 10.7 ± 0.8 −100 ± 8.7
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